Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Amandine Lebourgeois"'
Publikováno v:
Revue française des sciences de l’information et de la communication.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f4705b76ad0fe4e799202b7dd418a048
https://doi.org/10.4000/rfsic.12365
https://doi.org/10.4000/rfsic.12365
Autor:
Philippe Moreau, Thierry Guillaume, Antoine Bonnet, Anne Lok, Pierre Peterlin, Viviane Dubruille, Patrick Thomaré, Benoit Tessoulin, Steven Le Gouill, Amandine Lebourgeois, Cyrille Touzeau, Patrice Chevalier, Beatrice Mahe, Maxime Jullien, Alice Garnier, Sabrina Trudel, Nicolas Blin, Thomas Gastinne
Publikováno v:
Annals of Hematology. 98:1435-1440
The anti-CD38 monoclonal antibody daratumumab is approved as a single agent for the treatment of patients with relapsed and refractory multiple myeloma (RRMM) who have received at least three prior lines of therapy, including a proteasome inhibitor (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::187ccc1439c7b73d2a358c222c2e1263
https://doi.org/10.1007/s00277-019-03655-5
https://doi.org/10.1007/s00277-019-03655-5
Autor:
Amandine Lebourgeois, Gaëlle David, Béatrice Clémenceau, Thierry Guillaume, Katia Gagne, Ketevan Gendzekhadze, Patrice Chevallier, Catherine Willem, Pierre Peterlin, Léa Dubreuil, Marie C. Béné, Dhon Roméo Makanga, Alice Garnier, Anne Cesbron, Christelle Retière, Francesca Da Rin de Lorenzo, Nolwenn Legrand
Publikováno v:
Cancers
Cancers, MDPI, 2020, 12 (7), pp.1927. ⟨10.3390/cancers12071927⟩
Cancers, Vol 12, Iss 1927, p 1927 (2020)
Cancers, 2020, 12 (7), pp.1927. ⟨10.3390/cancers12071927⟩
Volume 12
Issue 7
Cancers, MDPI, 2020, 12 (7), pp.1927. ⟨10.3390/cancers12071927⟩
Cancers, Vol 12, Iss 1927, p 1927 (2020)
Cancers, 2020, 12 (7), pp.1927. ⟨10.3390/cancers12071927⟩
Volume 12
Issue 7
International audience; Natural killer (NK) cells are key cytotoxic effectors against malignant cells. Polygenic and polymorphic Killer cell Immunoglobulin-like Receptor (KIR) and HLA genes participate in the structural and functional formation of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42b9a5a0d13e2dd0e464c41d1a11aeaa
https://www.hal.inserm.fr/inserm-02913794
https://www.hal.inserm.fr/inserm-02913794
Autor:
Patrice Chevallier, Benoit Tessoulin, V. Dubruille, S. Le Gouill, Thierry Guillaume, A. Lok, Pierre Peterlin, Thomas Gastinne, Amandine Lebourgeois, Patrick Thomaré, P. Moreau, C. Touzeau, Béatrice Mahé, N. Blin, Maxime Jullien, Alice Garnier, Sabrina Trudel
Publikováno v:
HemaSphere. 3:965-966
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a2291abcff77ff00d5ce4578b300a686
https://doi.org/10.1097/01.hs9.0000567068.46311.5b
https://doi.org/10.1097/01.hs9.0000567068.46311.5b
Autor:
Aline Clavert, Virginie Roland, Lucie Planche, Thomas Gastinne, Steven Le Gouill, Viviane Dubruille, Cyrille Touzeau, Catherine Mohr, Thierry Guillaume, Patrice Chevallier, Benoit Tessoulin, Elsa Lestang, Philippe Moreau, Pierre Peterlin, Florent Malard, Sameh Ayari, Jacques Delaunay, Amandine Lebourgeois, Beatrice Mahe, Nicolas Blin, Mohamad Mohty, Marion Loirat, Karine Augeul-Meunier, Eolia Brissot
Publikováno v:
Blood. 120:3108-3108
Abstract 3108 Introduction: RIC regimens are increasingly used for allo-SCT in older patients or patients with co-morbidities. The FB2 regimen (Fludarabine 120–150 mg/m2 + I.V. Busulfan 6.4 mg/Kg + ATG 5 mg/Kg) using PBSC as stem cell source is cur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4913760ac1d80c6879b24d64df4412e8
https://doi.org/10.1182/blood.v120.21.3108.3108
https://doi.org/10.1182/blood.v120.21.3108.3108
Autor:
Eolia Brissot, Viviane Dubruille, Amandine Lebourgeois, Beatrice Mahe, Florent Malard, Nicolas Blin, Mohamad Mohty, Steven Le Gouill, Jacques Delaunay, Patrice Chevallier, Virginie Roland, Benoit Tessoulin, Thomas Gastinne, Cyrille Touzeau, Pierre Peterlin, Aline Clavert, Lucie Planche, Elsa Lestang, Thierry Guillaume, Sameh Ayari, Karine Augeul-Meunier, Marion Loirat, Catherine Mohr, Philippe Moreau
Publikováno v:
Blood. 120:4483-4483
Abstract 4483 Introduction: RIC regimens are increasingly used prior to allo-SCT. The FB2 regimen (Fludarabine 120–150 mg/m2 + IV Busulfan 6.4 mg/Kg + ATG Thymoglobuline 5mg/Kg) is currently the most widely used RIC regimen in many European centres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5caea54d7a241016f8d2396ad7671857
https://doi.org/10.1182/blood.v120.21.4483.4483
https://doi.org/10.1182/blood.v120.21.4483.4483
Autor:
Makanga, Dhon Roméo1,2,3 (AUTHOR) Dhon.Makanga@efs.sante.fr, Da Rin de Lorenzo, Francesca1,2,3 (AUTHOR) MarieChristine.BENE@chu-nantes.fr, David, Gaëlle1,2,3 (AUTHOR) Gaelle.David@efs.sante.fr, Willem, Catherine1,2,3 (AUTHOR) Beatrice.Clemenceau@univ-nantes.fr, Dubreuil, Léa1,2,3 (AUTHOR) lea.dubreuil@efs.sante.fr, Legrand, Nolwenn1,2,3 (AUTHOR) nolwenn.legrand@efs.sante.fr, Guillaume, Thierry2,4 (AUTHOR) Pierre.PETERLIN@chu-nantes.fr, Peterlin, Pierre4 (AUTHOR) amandinelebourgeois@wanadoo.fr, Lebourgeois, Amandine4 (AUTHOR) alice.garnier@chu-nantes.fr, Béné, Marie Christine2,3,5 (AUTHOR), Garnier, Alice4 (AUTHOR), Chevallier, Patrice2,3,4 (AUTHOR), Gendzekhadze, Ketevan6 (AUTHOR) kgendzek@coh.org, Cesbron, Anne1,7 (AUTHOR) Anne.Cesbron@efs.sante.fr, Gagne, Katia1,2,3,7 (AUTHOR) Katia.Gagne@efs.sante.fr, Clemenceau, Béatrice2,3 (AUTHOR), Retière, Christelle1,2,3 (AUTHOR) christelle.retiere@efs.sante.fr
Publikováno v:
Cancers. Jul2020, Vol. 12 Issue 7, p1927. 1p.
Autor:
Caillon, Hélène, Peterlin, Pierre, Chevallier, Patrice, Guillaume, Thierry, Lebourgeois, Amandine, Garnier, Alice, Ropert‐Bouchet, Martine, Dejoie, Thomas
Publikováno v:
British Journal of Haematology; Jul2019, Vol. 186 Issue 2, p365-366, 2p, 1 Graph